With the growing number of clinical trials and increased complexity
across the clinical lifecycle, life sciences organisations are under
more pressure than ever to improve study quality and execution.
Across the industry, there is widespread recognition of the need to
unify their clinical applications. Rik Van Mol at Veeva reveals nearuniversal
agreement that organisations need to streamline clinical
systems and processes and drive towards a unified clinical model,
which will speed study execution, improve study quality, ease
collaboration, and achieve greater visibility.